These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29911955)

  • 21. The costs of epilepsy and cost-based evaluations of anticonvulsants.
    Johnson WG
    Pharmacoeconomics; 1997 Oct; 12(4):446-59. PubMed ID: 10174311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study.
    Borghs S; Byram L; Chan J; Dedeken P; Logan J; Kiri V; Noack-Rink M; Patsalos PN; Thieffry S
    BMC Neurol; 2020 Jan; 20(1):7. PubMed ID: 31914953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost effectiveness of newer epilepsy treatments: a review of the literature on partial-onset seizures.
    Bolin K; Forsgren L
    Pharmacoeconomics; 2012 Oct; 30(10):903-23. PubMed ID: 22924967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis.
    Chisholm D;
    Epilepsia; 2005 May; 46(5):751-9. PubMed ID: 15857443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Cividini S; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD011412. PubMed ID: 35363878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
    Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
    Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review of economic evaluations of treatments for patients with epilepsy.
    Wijnen BFM; van Mastrigt GAPG; Evers SMAA; Gershuni O; Lambrechts DAJE; Majoie MHJM; Postulart D; Aldenkamp BAP; de Kinderen RJA
    Epilepsia; 2017 May; 58(5):706-726. PubMed ID: 28098939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic evaluation of antiepileptic drug therapy: a methodologic review.
    Levy P
    Epilepsia; 2002 May; 43(5):550-8. PubMed ID: 12027918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The "cost-benefit" analysis of new antiepileptic drugs].
    Vlasov PN; Orekhova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):39-43. PubMed ID: 22500311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy.
    Blais L; Sheehy O; St-Hilaire JM; Bernier G; Godfroid P; LeLorier JJ
    Pharmacoeconomics; 2005; 23(5):493-503. PubMed ID: 15896100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost evaluations in epilepsy: an update.
    Langfitt JT
    Epilepsia; 2000; 41 Suppl 2():S62-8. PubMed ID: 10885741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
    Glauser T; Ben-Menachem E; Bourgeois B; Cnaan A; Chadwick D; Guerreiro C; Kalviainen R; Mattson R; Perucca E; Tomson T
    Epilepsia; 2006 Jul; 47(7):1094-120. PubMed ID: 16886973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the Cost-effectiveness of Drug Treatment for Alzheimer Disease in a Simulation Model That Includes Caregiver and Societal Factors.
    Ito K; Chapman R; Pearson SD; Tafazzoli A; Yaffe K; Gurwitz JH
    JAMA Netw Open; 2021 Oct; 4(10):e2129392. PubMed ID: 34677596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis.
    Cruickshank M; Imamura M; Booth C; Aucott L; Counsell C; Manson P; Scotland G; Brazzelli M
    Health Technol Assess; 2022 Mar; 26(20):1-76. PubMed ID: 35333156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox-Gastaut Syndrome in the United Kingdom.
    Verdian L; Yi Y
    Seizure; 2010 Jan; 19(1):1-11. PubMed ID: 19942457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescribing antiepileptic drugs: should patients be switched on the basis of cost?
    Jobst BC; Holmes GL
    CNS Drugs; 2004; 18(10):617-28. PubMed ID: 15270592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of surgical treatment compared to medical treatment in patients with drug-refractory epilepsy: A systematic review.
    Kitschen A; Aleknonytė-Resch M; Sakalytė G; Diederich F
    Eur J Neurol; 2023 Mar; 30(3):749-761. PubMed ID: 36371643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspective and Costing in Cost-Effectiveness Analysis, 1974-2018.
    Kim DD; Silver MC; Kunst N; Cohen JT; Ollendorf DA; Neumann PJ
    Pharmacoeconomics; 2020 Oct; 38(10):1135-1145. PubMed ID: 32696192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-benefit analysis, cost-effectiveness analysis, and impact of antiepileptic drugs on the risk of fracture in patients with epilepsy: A nationwide cohort study.
    Cheng HH; Kung PT; Wang BR; Chiu LT; Tsai WC
    Epilepsy Behav; 2020 Feb; 103(Pt A):106851. PubMed ID: 31889639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.